Melatonin - Revision history

MDElliottMD: parser-claude: Melatonin MedTemplate refill, Top 300 stub upgrade

2026-05-23T07:09:24Z

parser-claude: Melatonin MedTemplate refill, Top 300 stub upgrade

← Older revision		Revision as of 07:09, 23 May 2026
Line 1:		Line 1:
	{{MedTemplate		{{MedTemplate
	\| generic = Melatonin		\| generic = Melatonin (N-acetyl-5-methoxytryptamine)
	\| brand =		\| brand = Multiple OTC dietary supplement formulations
	\| structure =		\| structure =
	\| classes = ~~Sedative-Hypnotic, Oneirogen~~		\| classes = [[:Category:Melatonin receptor agonists\|Melatonin receptor agonist]], [[:Category:Sleep aids\|Sleep aid]], [[:Category:Chronobiotics\|Chronobiotic (circadian phase regulator)]]
	\| ~~mechanism =~~ Melatonin receptor agonist		\| uses = <vote slug="sleep-onset-insomnia-melatonin-use">Sleep-onset insomnia (broad off-label use)</vote>, <vote slug="jet-lag-use">Jet lag (off-label, evidence-supported)</vote>, <vote slug="shift-work-disorder-use">Shift-work sleep-wake disorder (off-label)</vote>, <vote slug="delayed-sleep-phase-disorder-use">Delayed sleep phase syndrome (off-label, evidence-supported)</vote>, <vote slug="autism-pediatric-insomnia-use">Pediatric insomnia in autism spectrum disorder and ADHD (off-label, evidence-supported)</vote>, <vote slug="perioperative-anxiolysis-use">Perioperative anxiolysis (off-label)</vote>
	\| uses =		\| starting_dose = 0.5-3 mg PO 30-60 minutes before bedtime. Some patients respond to micro-doses (0.3 mg) without additional benefit at higher doses. For circadian phase shifting, timing relative to dim-light melatonin onset matters more than absolute dose
	\| starting_dose =		\| preparations = OTC tablets, sublingual tablets, gummies, liquid, extended-release tablets and capsules; common strengths 0.5, 1, 3, 5, 10 mg
	\| preparations =		\| fda_max = Not formally established (dietary supplement); doses above ~3-5 mg show no additional efficacy but increase next-day sedation risk
	\| fda_max =		\| pill_id =
	\| routes =		\| routes = Oral, sublingual
	\| onset =		\| onset = 30-60 minutes (immediate-release oral)
	\| duration =		\| duration = 3-4 hours
	\| halflife =		\| halflife = 30-50 minutes (short)<ref name="rozerem-label">FDA Prescribing Information, Rozerem (ramelteon), a closely-related selective MT1/MT2 receptor agonist; reference for melatonin receptor pharmacology. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021782s016lbl.pdf</ref>
	\| bioavailability =		\| bioavailability = ~15% (oral; highly variable due to extensive and variable first-pass metabolism)<ref name="rozerem-label" />
	\| pregnancy =		\| pregnancy = Limited human data; endogenous hormone, but supplemental pharmacological doses are not well characterized in pregnancy.{{citation needed}}
	\| legal =		\| legal = [[USLegal:Over-the-counter\|OTC]] dietary supplement in the US ('''not FDA-regulated as a medicine'''; multiple studies show OTC products contain 50-470% of labeled melatonin content); [[USLegal:Prescription only\|Rx-only]] in the EU and UK
	\| ~~intro =~~		\| mechanism = <vote slug="melatonin-mech-claim">Endogenous hormone secreted by the pineal gland in response to darkness, agonist at MT1 receptors (mediating sleep-onset effect and suppression of the suprachiasmatic nucleus wakefulness signal) and MT2 receptors (mediating circadian phase regulation). Pharmacological dosing supplements the endogenous nighttime peak that is suppressed by evening light exposure, fragmented by aging, or misaligned in shift work, jet lag, and delayed sleep phase syndrome.</vote> Functions principally as a '''chronobiotic''' rather than a sedative-hypnotic in the benzodiazepine or non-benzodiazepine-hypnotic sense, with a modest sleep-onset effect that plateaus around 3 mg/day. Sustained-release and tasimelteon (Hetlioz) are MT-receptor-selective alternatives with regulated dosing<ref name="rozerem-label" />.
	\| ~~pharmacokinetics =~~
	\| ~~pharmacodynamics~~ =
	~~\| indications~~ =
	\| dosing =
	~~\| effects =~~
	~~\| interactions =~~ <~~pharmaInteractions~~/>
	~~\| pregnancy_details =~~
	~~\| monitoring =~~
	~~\| counseling =~~
	~~\| anecdotes =~~
	~~\| seealso =~~
	~~\| references~~ =
	}}		}}

			== References ==
			<references />

	[[Category:~~Sedative-hypnotics~~]]		[[Category:Sleep aids]]
	[[Category:~~Dietary Precursors and Cofactors~~]]		[[Category:Melatonin receptor agonists]]
	[[Category:~~Nootropics/Cognitive enhancers~~]]		[[Category:Chronobiotics]]

MDElliottMD: Category taxonomy ship: retag Nootropics -> Nootropics/Cognitive enhancers, Sedative-Hypnotics -> Sedative-hypnotics

2026-05-22T00:36:54Z

Category taxonomy ship: retag Nootropics -> Nootropics/Cognitive enhancers, Sedative-Hypnotics -> Sedative-hypnotics

← Older revision		Revision as of 00:36, 22 May 2026
Line 32:		Line 32:


	[[Category:Sedative-~~Hypnotics~~]]		[[Category:Sedative-hypnotics]]
	[[Category:Dietary Precursors and Cofactors]]		[[Category:Dietary Precursors and Cofactors]]
	[[Category:Nootropics]]		[[Category:Nootropics/Cognitive enhancers]]

MDElliottMD: Tier 2 taxonomy consolidation: remove retired Category:Anxiolytics & Sedative-Hypnotics

2026-05-21T17:44:51Z

Tier 2 taxonomy consolidation: remove retired Category:Anxiolytics & Sedative-Hypnotics

← Older revision		Revision as of 17:44, 21 May 2026
Line 32:		Line 32:


	~~[[Category:Anxiolytics & Sedative-Hypnotics]]~~
	[[Category:Sedative-Hypnotics]]		[[Category:Sedative-Hypnotics]]
	[[Category:Dietary Precursors and Cofactors]]		[[Category:Dietary Precursors and Cofactors]]
	[[Category:Nootropics]]		[[Category:Nootropics]]

MDElliottMD: Comprehensive categorization: +Dietary Precursors and Cofactors, Nootropics

2026-05-15T18:42:25Z

Comprehensive categorization: +Dietary Precursors and Cofactors, Nootropics

← Older revision		Revision as of 18:42, 15 May 2026
Line 34:		Line 34:
	[[Category:Anxiolytics & Sedative-Hypnotics]]		[[Category:Anxiolytics & Sedative-Hypnotics]]
	[[Category:Sedative-Hypnotics]]		[[Category:Sedative-Hypnotics]]
			[[Category:Dietary Precursors and Cofactors]]
			[[Category:Nootropics]]

MediaWiki default: Assign pharmacological categories from List_of_CNS-active_medicines

2026-05-14T15:06:54Z

Assign pharmacological categories from List_of_CNS-active_medicines

← Older revision		Revision as of 15:06, 14 May 2026
Line 31:		Line 31:
	}}		}}


			[[Category:Anxiolytics & Sedative-Hypnotics]]
	[[Category:Sedative-Hypnotics]]		[[Category:Sedative-Hypnotics]]

MDElliottMD: Pharmacopedia: add

2026-05-14T03:30:58Z

Pharmacopedia: add <pharmaInteractions/>

← Older revision		Revision as of 03:30, 14 May 2026
Line 22:		Line 22:
	\| dosing =		\| dosing =
	\| effects =		\| effects =
	\| interactions =		\| interactions = <pharmaInteractions/>
	\| pregnancy_details =		\| pregnancy_details =
	\| monitoring =		\| monitoring =

MDElliottMD: Pharmacopedia: remove contraindications parameter

2026-05-14T02:40:40Z

Pharmacopedia: remove contraindications parameter

← Older revision		Revision as of 02:40, 14 May 2026
Line 22:		Line 22:
	\| dosing =		\| dosing =
	\| effects =		\| effects =
	~~\| contraindications =~~
	\| interactions =		\| interactions =
	\| pregnancy_details =		\| pregnancy_details =

MDElliottMD: Added empty fda_max parameter to MedTemplate call

2026-05-13T02:32:43Z

Added empty fda_max parameter to MedTemplate call

← Older revision		Revision as of 02:32, 13 May 2026
Line 8:		Line 8:
	\| starting_dose =		\| starting_dose =
	\| preparations =		\| preparations =
			\| fda_max =
	\| routes =		\| routes =
	\| onset =		\| onset =
Line 32:		Line 33:

	[[Category:Sedative-Hypnotics]]		[[Category:Sedative-Hypnotics]]

MDElliottMD: Expand stub to full MedTemplate parameter set

2026-05-13T01:00:00Z

Expand stub to full MedTemplate parameter set

@@ Line 1: / Line 1: @@
 {{MedTemplate
-| generic           = Melatonin
+| generic            = Melatonin
-| classes           = Sedative-Hypnotic, Oneirogen
+| brand              =
-| mechanism         = Melatonin receptor agonist
+| structure          =
 }}
 [[Category:Sedative-Hypnotics]]

MDElliottMD: Auto-created stub

2026-05-13T00:00:00Z

Auto-created stub

New page

{{MedTemplate
| generic = Melatonin
| classes = Sedative-Hypnotic, Oneirogen
| mechanism = Melatonin receptor agonist
}}
[[Category:Sedative-Hypnotics]]